Healthcare providers can only prescribe semaglutide, specifically Wegovy, if the patient has a body mass index (BMI) over 30 or a BMI of 27 or above and at least one comorbidity
However, significant changes in weight and overall metabolic health can take longer, often several weeks to a few months, as the medication helps to regulate insulin secretion, reduce appetite, and promote weight loss
8 (10), e77284 (2013)
This could be due to the evidence suggesting that BMI is inversely proportional to central ATP production [186] and that obesity is associated with brain atrophy and cognitive decline
Glutatyon tedavisi, vcudun antioksidan kapasitesini artrmak ve toksinlerden arnmasn desteklemek amacyla uygulanan bir yntemdir
However, they can be unpleasant for some patients, affecting their ability to tolerate and adhere to the therapy